1. Home
  2. DRUG vs BNED Comparison

DRUG vs BNED Comparison

Compare DRUG & BNED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRUG
  • BNED
  • Stock Information
  • Founded
  • DRUG 2019
  • BNED 1965
  • Country
  • DRUG United States
  • BNED United States
  • Employees
  • DRUG N/A
  • BNED N/A
  • Industry
  • DRUG Pharmaceuticals and Biotechnology
  • BNED Other Specialty Stores
  • Sector
  • DRUG Health Care
  • BNED Consumer Discretionary
  • Exchange
  • DRUG Nasdaq
  • BNED Nasdaq
  • Market Cap
  • DRUG 364.8M
  • BNED 314.0M
  • IPO Year
  • DRUG N/A
  • BNED N/A
  • Fundamental
  • Price
  • DRUG $56.97
  • BNED $7.40
  • Analyst Decision
  • DRUG Strong Buy
  • BNED
  • Analyst Count
  • DRUG 9
  • BNED 0
  • Target Price
  • DRUG $81.67
  • BNED N/A
  • AVG Volume (30 Days)
  • DRUG 190.6K
  • BNED 175.7K
  • Earning Date
  • DRUG 12-30-2025
  • BNED 12-08-2025
  • Dividend Yield
  • DRUG N/A
  • BNED N/A
  • EPS Growth
  • DRUG N/A
  • BNED N/A
  • EPS
  • DRUG N/A
  • BNED N/A
  • Revenue
  • DRUG N/A
  • BNED $1,567,800,000.00
  • Revenue This Year
  • DRUG N/A
  • BNED $2.74
  • Revenue Next Year
  • DRUG N/A
  • BNED N/A
  • P/E Ratio
  • DRUG N/A
  • BNED N/A
  • Revenue Growth
  • DRUG N/A
  • BNED N/A
  • 52 Week Low
  • DRUG $23.18
  • BNED $7.21
  • 52 Week High
  • DRUG $70.23
  • BNED $14.41
  • Technical
  • Relative Strength Index (RSI)
  • DRUG 49.89
  • BNED 23.27
  • Support Level
  • DRUG $55.01
  • BNED $8.83
  • Resistance Level
  • DRUG $61.81
  • BNED $8.96
  • Average True Range (ATR)
  • DRUG 3.80
  • BNED 0.36
  • MACD
  • DRUG -0.06
  • BNED -0.17
  • Stochastic Oscillator
  • DRUG 61.06
  • BNED 7.59

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is an operator of bookstores in college and university campuses across the United States. The company is also engaged in providing digital education services. It operates in three reportable segments that include Retail offers existing and prospective clients the flexibility of physical, virtual, or custom store solutions, and wholesale is comprised of the wholesale and virtual retail fulfillment, and support operations of the MBS subsidiary, also Corporate Services represent unallocated shared-service costs which include corporate level expenses and other governance functions, including executive functions, such as accounting, legal, treasury, information technology, and human resources. It earns majority of the revenue from Retail segment.

Share on Social Networks: